BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28595088)

  • 1. The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.
    Carol EE; Spencer RL; Mittal VA
    Psychoneuroendocrinology; 2017 Sep; 83():58-64. PubMed ID: 28595088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders.
    Carol EE; Mittal VA
    Psychoneuroendocrinology; 2015 Jul; 57():26-36. PubMed ID: 25880698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in morning cortisol in youth at ultra-high-risk for psychosis.
    Carol EE; Spencer RL; Mittal VA
    Psychoneuroendocrinology; 2016 Oct; 72():87-93. PubMed ID: 27388688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.
    Nordholm D; Rostrup E; Mondelli V; Randers L; Nielsen MØ; Wulff S; Nørbak-Emig H; Broberg BV; Krakauer K; Dazzan P; Zunszain PA; Nordentoft M; Glenthøj B
    Psychoneuroendocrinology; 2018 Jun; 92():72-80. PubMed ID: 29635174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis.
    Pruessner M; Bechard-Evans L; Pira S; Joober R; Collins DL; Pruessner JC; Malla AK
    Psychol Med; 2017 Feb; 47(3):471-483. PubMed ID: 27774914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposure.
    Monteleone P; Di Filippo C; Fabrazzo M; Milano W; Martiadis V; Corrivetti G; Monteleone AM; Maj M
    Psychiatry Res; 2014 Feb; 215(2):263-7. PubMed ID: 24388728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis reactivity to social stress and adolescent cannabis use: the TRAILS study.
    van Leeuwen AP; Creemers HE; Greaves-Lord K; Verhulst FC; Ormel J; Huizink AC
    Addiction; 2011 Aug; 106(8):1484-92. PubMed ID: 21631618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.
    van Tricht MJ; Harmsen EC; Koelman JH; Bour LJ; van Amelsvoort TA; Linszen DH; de Haan L; Nieman DH
    Int J Psychophysiol; 2013 May; 88(2):149-56. PubMed ID: 23541998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted cortisol awakening response in people at ultra high risk of developing psychosis.
    Day FL; Valmaggia LR; Mondelli V; Papadopoulos A; Papadopoulos I; Pariante CM; McGuire P
    Schizophr Res; 2014 Sep; 158(1-3):25-31. PubMed ID: 25048422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis measures and cognitive abilities in early psychosis: Are there sex differences?
    Labad J; Gutiérrez-Zotes A; Creus M; Montalvo I; Cabezas Á; Solé M; Ortega L; Algora MJ; Sánchez-Gistau V; Vilella E
    Psychoneuroendocrinology; 2016 Oct; 72():54-62. PubMed ID: 27344379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis function and exposure to stress factors and cannabis use in recent-onset psychosis.
    Labad J; Ortega L; Cabezas Á; Montalvo I; Arranz S; Algora MJ; Solé M; Martorell L; Vilella E; Sánchez-Gistau V
    World J Biol Psychiatry; 2020 Sep; 21(7):564-571. PubMed ID: 31244371
    [No Abstract]   [Full Text] [Related]  

  • 14. HPA-axis function and grey matter volume reductions: imaging the diathesis-stress model in individuals at ultra-high risk of psychosis.
    Valli I; Crossley NA; Day F; Stone J; Tognin S; Mondelli V; Howes O; Valmaggia L; Pariante C; McGuire P
    Transl Psychiatry; 2016 May; 6(5):e797. PubMed ID: 27138796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
    Kraan T; Velthorst E; Koenders L; Zwaart K; Ising HK; van den Berg D; de Haan L; van der Gaag M
    Psychol Med; 2016 Mar; 46(4):673-81. PubMed ID: 26568030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress and HPA-axis functioning in young people at ultra high risk for psychosis.
    Thompson KN; Phillips LJ; Komesaroff P; Yuen HP; Wood SJ; Pantelis C; Velakoulis D; Yung AR; McGorry PD
    J Psychiatr Res; 2007 Oct; 41(7):561-9. PubMed ID: 16831447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
    Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
    Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective effects of cannabis before the first psychotic episode.
    Peters BD; de Koning P; Dingemans P; Becker H; Linszen DH; de Haan L
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1155-62. PubMed ID: 20001415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis.
    Collip D; Nicolson NA; Lardinois M; Lataster T; van Os J; Myin-Germeys I;
    Psychol Med; 2011 Nov; 41(11):2305-15. PubMed ID: 21733219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.